Pharmaceutical compositions to treat tobacco addiction or nicotine addiction, to relieve symptoms of nicotine withdrawal or to facilitate smoking cessation, to treat cocaine addiction and associated withdrawal effects, to treat alcohol dependence and associated withdrawal effects, and , processes to treat tobacco addiction or nicotine addiction, to relieve nicotine withdrawal symptoms or to facilitate smoking cessation, to treat cocaine addiction and associated withdrawal effects, and to treat alcohol dependence and associated withdrawal effects

摘要

'' PHARMACEUTICAL COMPOSITIONS TO TREAT TOBACCO ADDICTION OR NICOTIN ADDICTION, TO RELIEVE NICOTIN ABSTINENCE SYMPTOMS OR TO FACILITATE SMOKING CESSATION AND TO TREAT COCAINE ADDICTION AND EFFECTS OF ABOINING AFFECTIVITY , AND, PROCESSES TO TREAT TOBACCO ADDICTION OR NICOTIN ADDICTION, TO RELIEVE NICOTIN WITHDRAWAL SYMPTOMS OR TO FACILITATE SMOKING CESSATION, TO TREAT COCAINE ADDICTION AND EFFECTS OF ASSOCIATED EFFECTIVENESS AND ABDENTAL ABSTINANCE ASSOCIATES ''. The present invention relates to the processes of treating patients suffering from tobacco addiction and nicotine addiction, to alleviate the effects of nicotine withdrawal, to provide or facilitate the effects of smoking cessation therapies and as maintenance therapy long-term smoking cessation. The invention also includes related pharmaceutical compositions comprising nicotine receptor antagonists and an antidepressant or anti-anxiety drug. Specific drug combinations (mecamylamine HC1 and bupropion HC1) as well as mecamylanine in combination with certain classes of drugs (for example, anti-anxiety and antidepressant drugs) comprise the described pharmaceutical compositions. These compositions are also contemplated for use in the treatment of cocaine addiction and in the treatment of alcohol dependence.